Results for tag: "Roflumilast"

Roflumilast is a prescription drug used to treat chronic obstructive pulmonary disease (COPD). It is a phosphodiesterase-4 (PDE-4) inhibitor, which works by reducing inflammation in the lungs. It is used to reduce the frequency and severity of COPD exacerbations, and to improve lung function and quality of life. Roflumilast is available in tablet form and is taken once daily. Roflumilast is marketed by several pharmaceutical companies, including AstraZeneca, Novartis, and Sunovion Pharmaceuticals. It is also available in generic form from several generic drug manufacturers. The drug is approved for use in the United States, Canada, Europe, and other countries. Companies in the Roflumilast market include AstraZeneca, Novartis, Sunovion Pharmaceuticals, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more